InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: None

Wednesday, 04/18/2018 1:25:23 PM

Wednesday, April 18, 2018 1:25:23 PM

Post# of 6377
No word on today's presentation?

Here is a significant statement from the poster.

"There was an eighty-six percent decrease in tumor burden (p<0.05), and multinodular burden (p<0.01) in the combination prexigebersen/paclitaxel group compared to control. Prexigebersen shows promising preclinical efficacy and may be a novel therapeutic strategy in gynecologic malignancies."



http://www.abstractsonline.com/pp8/#!/4562/presentation/6816
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News